Chronic Fatigue Therapy

Product NDC: 17312-020
11-digit product format: 173120020
Labeler code: 17312
Product ID: 17312-020_e17019f3-d2e9-4920-b6ca-985a89f5e6bf
Type: HUMAN OTC DRUG
Nonproprietary name: EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -
Dosage form: TABLET, ORALLY DISINTEGRATING
Route: ORAL
Labeler: TRP Company
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 2011-12-01
Marketing end: 0000-00-00
Substance: EPINEPHRINE; GOLD; HUMAN BREAST TUMOR CELL; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; INFLUENZA B VIRUS; PHOSPHORIC ACID; SCUTELLARIA LATERIFLORA TOP
Active strength: 3 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	17312-020		I	Inactivated by FDA		2026-10-12
excluded package	package	17312-020	17312-020-14	I	Inactivated by FDA		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17312-020-14	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17312-020-14	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17312-020-14	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17312-020-14	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17312-020-14	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17312-020-14	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17312-020-14	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17312-020-14	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17312-020-14	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	17312-020-14	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	17312-020-14	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	17312-020-14	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	17312-020-14	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17312-020-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17312-020-14	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	17312-020-14	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	17312-020-14	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	17312-020-14	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	17312-020-14	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	17312-020-14	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	17312-020-14	`9bebd1f3094a…`	`5416666fcb17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
0b4ec9ca-d305-43fc-88dd-7a510313efe0	Product name	1	20260105
bb209f42-a85f-4fee-9d3d-c9dded168625	Product name	1	20251208
49628fc7-2031-4c28-bd31-0ef3aa8f44a3	Product name	3	20251118
cbf85893-59ef-423f-87d4-a573c000a8b9	Product name	8	20250731
b5b1095b-40cd-8a9e-b111-502545045b07	Product name	4	20250325
e190029e-423b-473c-8e04-2ada59b5b711	Product name	1	20250314
e0031c74-3853-42bc-8e10-86dbbe83992e	Product name	2	20231116
f7046b89-2016-499a-adc6-78479172abc6	Product name	1	20230425
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
2686d634-e712-4007-8dbf-3d37c6c4d71f	Product name	1	20181121
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
bd49bb86-2d32-4a7a-a594-eeda2e29af42	Product name	1	20180118
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
3becbe78-12d9-4ad2-9b4c-1e36f8d1303a	Product name	1	20170815
6084a4f4-5437-c9a5-caec-5361ee075a59	Product name	1	20140508
90c5639a-61b0-88d6-ddcf-21888e94869a	Product name	1	20140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
17312-020-14	2020-01-31	C162847	48780-1	9d75b9d0-3aed-f424-e053-dadaa90a57ce	Chronic Fatigue Therapy™ Homeopathic Fast Dissolving Tablets

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
17312-020-14	Chronic Fatigue Therapy	1 in 1 PACKAGE	TABLET, ORALLY DISINTEGRATING	1		1
17312-020-14	Chronic Fatigue Therapy	70 in 1 BOTTLE	TABLET, ORALLY DISINTEGRATING	70		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ECHINACEA, UNSPECIFIED	ACTIVE INGREDIENT	4N9P6CC1DX	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
EPINEPHRINE	ACTIVE INGREDIENT	YKH834O4BH	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
GELSEMIUM SEMPERVIRENS ROOT	ACTIVE INGREDIENT	639KR60Q1Q	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
GINKGO	ACTIVE INGREDIENT	19FUJ2C58T	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
GOLD	ACTIVE INGREDIENT	79Y1949PYO	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
HUMAN BREAST TUMOR CELL	ACTIVE INGREDIENT	C62OO7VD9K	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
INFLUENZA B VIRUS	ACTIVE INGREDIENT	1314JZ2X6W	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
PHOSPHORIC ACID	ACTIVE INGREDIENT	E4GA8884NN	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
SCUTELLARIA LATERIFLORA TOP	ACTIVE INGREDIENT	C6CNB75R61	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
ECHINACEA, UNSPECIFIED	ACTIVE MOIETY	4N9P6CC1DX	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
EPINEPHRINE	ACTIVE MOIETY	YKH834O4BH	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
GELSEMIUM SEMPERVIRENS ROOT	ACTIVE MOIETY	639KR60Q1Q	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
GINKGO	ACTIVE MOIETY	19FUJ2C58T	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
GOLD	ACTIVE MOIETY	79Y1949PYO	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
HUMAN BREAST TUMOR CELL	ACTIVE MOIETY	C62OO7VD9K	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
INFLUENZA B VIRUS	ACTIVE MOIETY	1314JZ2X6W	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
PHOSPHORIC ACID	ACTIVE MOIETY	E4GA8884NN	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
SCUTELLARIA LATERIFLORA TOP	ACTIVE MOIETY	C6CNB75R61	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
COPOVIDONE	INACTIVE INGREDIENT	D9C330MD8B	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1
SORBITOL	INACTIVE INGREDIENT	506T60A25R	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17312-020	CHRONIC FATIGUE THERAPY (EPINEPHRINE - GOLD - HUMAN BREAST TUMOR CELL - ECHINACEA, UNSPECIFIED - GELSEMIUM SEMPERVIRENS ROOT - GINKGO - INFLUENZA B VIRUS - PHOSPHORIC ACID - SCUTELLARIA LATERIFLORA TOP -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]	1	Legacy NDC, 2 package rows	20121031_1999abf5-0817-44cd-aceb-b20e910e3064.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
YKH834O4BH	EPINEPHRINE	51-43-4	EPINEPHRINE
79Y1949PYO	GOLD	7440-57-5	GOLD
C62OO7VD9K	HUMAN BREAST TUMOR CELL		HUMAN BREAST TUMOR CELL
4N9P6CC1DX	ECHINACEA, UNSPECIFIED		ECHINACEA, UNSPECIFIED
639KR60Q1Q	GELSEMIUM SEMPERVIRENS ROOT		GELSEMIUM SEMPERVIRENS ROOT
19FUJ2C58T	GINKGO	90045-36-6	GINKGO
1314JZ2X6W	INFLUENZA B VIRUS		INFLUENZA B VIRUS
E4GA8884NN	PHOSPHORIC ACID	7664-38-2	PHOSPHORIC ACID
C6CNB75R61	SCUTELLARIA LATERIFLORA TOP		SCUTELLARIA LATERIFLORA TOP

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
17312-020-14	17312002014	1 in 1 PACKAGE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Chronic Fatigue Therapy™ Homeopathic Fast Dissolving Tablets	TRP Company	2012-10-30	HUMAN OTC DRUG LABEL	1